We are live on ! Find out more
CCM

Consonance Capital Management Portfolio holdings

AUM $7.28M
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+39.83%
1 Year Est. Return
-43.59%
3 Year Est. Return
+313.86%
5 Year Est. Return
+886.32%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$332M
Cap. Flow
+$148M
Cap. Flow %
14.28%
Top 10 Hldgs %
79.18%
Holding
32
New
10
Increased
5
Reduced
4
Closed
9

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$72.3M
2
AMRN
Amarin Corp
AMRN
+$69.1M
3
AKRX
Akorn Inc
AKRX
+$65.2M
4
UTHR icon
United Therapeutics
UTHR
+$48.1M
5
MD icon
Pediatrix Medical
MD
+$45.1M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$76.6M
2
ASRT
Assertio
ASRT
+$44.6M
3
PEN icon
Penumbra
PEN
+$40.7M
4
OFIX icon
Orthofix Medical
OFIX
+$26.3M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$22.8M

Sector Composition

Rank Sector Weight
1 Healthcare 92.73%
2 Financials 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
26
Pacific Biosciences
PACB
$460M
– –
-1,114,448
Closed -$7.84M
PEN icon
27
Penumbra
PEN
$12.6B
– –
-684,079
Closed -$40.7M
EGRX
28
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-482,047
Closed -$18.7M
NUVA
29
DELISTED
NuVasive, Inc.
NUVA
– –
-165,203
Closed -$9.87M
NXTM
30
DELISTED
NxStage Medical Inc.
NXTM
– –
-835,134
Closed -$18.1M
CPHD
31
DELISTED
Cepheid Inc
CPHD
– –
-453,662
Closed -$13.9M
MDVN
32
DELISTED
MEDIVATION, INC.
MDVN
– –
-1,270,000
Closed -$76.6M
1
2

Similar funds

GPC
Garrison Point Capital Walnut Creek, California $6.82M AUM 21.38% 1-Year Est. Return
BPM
Bronson Point Management Fairfield, Connecticut $8.26M AUM 46.43% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
TPMI
Tilden Park Management I New York $5.38M AUM 28.49% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
SCG
Siris Capital Group New York $9.42M AUM 42.79% 1-Year Est. Return
CVGI
Craft Ventures GP I San Francisco, California $9.51M AUM 95.77% 1-Year Est. Return

Consonance Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Consonance Capital Management held 32 positions worth $1.04B, up 47% from $707M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Consonance Capital Management deployed $148M of net new capital in Q3 2016, opening 10 new positions and adding to 5 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 3,698,903 shares worth $67.1M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 89% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Orthofix Medical, an estimated $26.3M trimmed.

  • Consonance Capital Management's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 3,698,903 shares worth $67.1M.
  • Consonance Capital Management added most to United Therapeutics in Q3 2016, an estimated $48.1M increase.
  • Consonance Capital Management's biggest Q3 2016 reduction was Orthofix Medical, cutting an estimated $26.3M.
  • Consonance Capital Management fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $76.6M.
  • Consonance Capital Management's ten largest holdings make up 79% of its $1.04B portfolio in Q3 2016.
  • Consonance Capital Management opened 10 new positions and closed 9 in Q3 2016.
  • Consonance Capital Management's portfolio value rose 47% quarter-over-quarter to $1.04B.

Based on Consonance Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.